(Q42831234)

8 November 2017

Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin (English)

1 reference

8 November 2017

Er-Jia Wang

1

1 reference

8 November 2017

Mary Barecki-Roach

series ordinal

2

1 reference

8 November 2017

William W Johnson

series ordinal

3

1 reference

8 November 2017

1 January 2004

1 reference

Journal of Pharmacy and Pharmacology

8 November 2017

1 reference

8 November 2017

56

1 reference

8 November 2017

1

1 reference

8 November 2017

123-128

1 reference

Relation between the turnover number for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein

8 November 2017

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

St John's wort for depression: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Biochemistry of multidrug resistance mediated by the multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

St John's wort (Hypericum perforatum): drug interactions and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

St Johns wort increases expression of P-glycoprotein: implications for drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Correlation between steady-state ATP hydrolysis and vanadate-induced ADP trapping in Human P-glycoprotein. Evidence for ADP release as the rate-limiting step in the catalytic cycle and its modulation by substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

St. John's wort for depression: a meta-analysis of well-defined clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Indinavir concentrations and St John's wort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Characterization of the catalytic cycle of ATP hydrolysis by human P-glycoprotein. The two ATP hydrolysis events in a single catalytic cycle are kinetically similar but affect different functional outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Effect of St John's wort on the pharmacokinetics of fexofenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Functional reconstitution of P-glycoprotein reveals an apparent near stoichiometric drug transport to ATP hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Acute heart transplant rejection due to Saint John's wort

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Two transport binding sites of P-glycoprotein are unequal yet contingent: initial rate kinetic analysis by ATP hydrolysis demonstrates intersite dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

Cooperativity in the inhibition of P-glycoprotein-mediated daunorubicin transport: evidence for half-of-the-sites reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357022395

21 January 2018

Identifiers

DOI

10.1211/0022357022395

1 reference

release_pshsmnsrcbg73atgyxuq2qfgtm

8 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pshsmnsrcbg73atgyxuq2qfgtm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference